| 72 | Humans |
| 57 | Parkinson Disease |
| 43 | Male |
| 36 | Female |
| 34 | Aged |
| 28 | Middle Aged |
| 24 | Animals |
| 15 | Adult |
| 12 | Brain |
| 10 | Mutation |
| 8 | Mice |
| 8 | Aged, 80 and over |
| 7 | Neuropsychological Tests |
| 7 | Deep Brain Stimulation |
| 6 | Treatment Outcome |
| 6 | Severity of Illness Index |
| 6 | Cohort Studies |
| 5 | alpha-Synuclein |
| 5 | Ubiquitin-Protein Ligases |
| 5 | Multiple System Atrophy |
| 5 | Mice, Inbred C57BL |
| 5 | Magnetic Resonance Imaging |
| 5 | Levodopa |
| 5 | Gene Expression Regulation |
| 5 | Canada |
| 5 | Antiparkinson Agents |
| 4 | Surveys and Questionnaires |
| 4 | Sequence Alignment |
| 4 | Risk Factors |
| 4 | Prevalence |
| 4 | Phenotype |
| 4 | Pedigree |
| 4 | Molecular Sequence Data |
| 4 | Longitudinal Studies |
| 4 | Genomics |
| 4 | Genetic Predisposition to Disease |
| 4 | Emotions |
| 4 | Disease Models, Animal |
| 4 | Databases, Factual |
| 4 | Conserved Sequence |
| 4 | Cognition |
| 4 | Case-Control Studies |
| 4 | Amino Acid Sequence |
| 4 | Age of Onset |
| 3 | tau Proteins |
| 3 | United States |
| 3 | Time Factors |
| 3 | Supranuclear Palsy, Progressive |
| 3 | Spain |
| 3 | Quality of Life |
| 3 | Protein-Serine-Threonine Kinases |
| 3 | Protein Conformation |
| 3 | Polymorphism, Single Nucleotide |
| 3 | Motor Activity |
| 3 | Models, Molecular |
| 3 | Mitochondria |
| 3 | Lewy Body Disease |
| 3 | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
| 3 | Italy |
| 3 | Incidence |
| 3 | Haplotypes |
| 3 | Genome-Wide Association Study |
| 3 | Genetic Association Studies |
| 3 | Functional Laterality |
| 3 | Double-Blind Method |
| 3 | Dopamine Agents |
| 3 | Dementia |
| 3 | Computational Biology |
| 3 | Apolipoproteins E |
| 3 | Analysis of Variance |
| 2 | Virulence |
| 2 | United Kingdom |
| 2 | Ubiquitin |
| 2 | Toxoplasma |
| 2 | Synteny |
| 2 | Subthalamus |
| 2 | Speech Perception |
| 2 | Sleep Wake Disorders |
| 2 | Sex Factors |
| 2 | Sequence Homology, Amino Acid |
| 2 | Risk |
| 2 | Retrospective Studies |
| 2 | Restless Legs Syndrome |
| 2 | Reproducibility of Results |
| 2 | Rats |
| 2 | Radiopharmaceuticals |
| 2 | RNA, Messenger |
| 2 | Psychiatric Status Rating Scales |
| 2 | Protozoan Proteins |
| 2 | Proteome |
| 2 | Prospective Studies |
| 2 | Positron-Emission Tomography |
| 2 | Piperidines |
| 2 | Phylogeny |
| 2 | Pedunculopontine Tegmental Nucleus |
| 2 | Neuroimaging |
| 2 | Nervous System Diseases |
| 2 | Motor Cortex |
| 2 | Molecular Targeted Therapy |
| 2 | Mice, Transgenic |
| 2 | Mice, Knockout |
| 2 | Metabolic Networks and Pathways |
| 2 | Memory |
| 2 | Japan |
| 2 | Internet |
| 2 | Homeostasis |
| 2 | High-Throughput Screening Assays |
| 2 | Germany |
| 2 | Genome, Protozoan |
| 2 | Genetic Variation |
| 2 | Genetic Loci |
| 2 | Gene Expression Profiling |
| 2 | Gait Disorders, Neurologic |
| 2 | France |
| 2 | Follow-Up Studies |
| 2 | Facial Expression |
| 2 | Executive Function |
| 2 | Enzyme Activation |
| 2 | Electroencephalography |
| 2 | Electric Stimulation Therapy |
| 2 | Drug Delivery Systems |
| 2 | Dose-Response Relationship, Drug |
| 2 | Dopaminergic Neurons |
| 2 | Dopamine |
| 2 | Dopamine Agonists |
| 2 | Disease Progression |
| 2 | Dihydroxyphenylalanine |
| 2 | Decision Making |
| 2 | Cues |
| 2 | Cross-Cultural Comparison |
| 2 | Cognition Disorders |
| 2 | Coccidiosis |
| 2 | Clinical Trials as Topic |
| 2 | Carrier Proteins |
| 2 | Brain Mapping |
| 2 | Biomarkers |
| 2 | Base Sequence |
| 2 | Autophagy |
| 2 | Animal Experimentation |
| 2 | Alzheimer Disease |
| 2 | Alleles |
| 2 | Algorithms |
| 2 | Aging |
| 2 | Age Factors |
| 2 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 1 | gamma-Aminobutyric Acid |
| 1 | Zoonoses |
| 1 | Young Adult |
| 1 | Videotape Recording |
| 1 | Vesicular Transport Proteins |
| 1 | Verbal Behavior |
| 1 | Ventral Thalamic Nuclei |
| 1 | Ventral Striatum |
| 1 | Urea |
| 1 | Ubiquitination |
| 1 | Ubiquitin-Conjugating Enzymes |
| 1 | Tyrosine 3-Monooxygenase |
| 1 | Tremor |
| 1 | Transdermal Patch |
| 1 | Transcription, Genetic |
| 1 | Transcription Factors |
| 1 | Transcranial Magnetic Stimulation |
| 1 | Transcranial Direct Current Stimulation |
| 1 | Toxoplasmosis |
| 1 | Tomography, Emission-Computed |
| 1 | Tomography, Emission-Computed, Single-Photon |
| 1 | Toll-Like Receptor 2 |
| 1 | Tissue Banks |
| 1 | Thromboembolism |
| 1 | Thiophenes |
| 1 | Theta Rhythm |
| 1 | Theory of Mind |
| 1 | Tetrahydronaphthalenes |
| 1 | Terminology as Topic |
| 1 | Temporal Lobe |
| 1 | Task Performance and Analysis |
| 1 | Taenia solium |
| 1 | Synovitis |
| 1 | Sweating |
| 1 | Substrate Specificity |
| 1 | Stroke |
| 1 | Stem Cells |
| 1 | Statistics, Nonparametric |
| 1 | Species Specificity |
| 1 | Space Perception |
| 1 | Software |
| 1 | Sodium-Potassium-Exchanging ATPase |
| 1 | Societies, Medical |
| 1 | Social Perception |
| 1 | Signal Transduction |
| 1 | Shaw Potassium Channels |
| 1 | Sequence Homology |
| 1 | Sequence Analysis, DNA |
| 1 | Sensitivity and Specificity |
| 1 | Semantics |
| 1 | Seasonal Affective Disorder |
| 1 | Rotation |
| 1 | Rotarod Performance Test |
| 1 | Reverse Transcriptase Polymerase Chain Reaction |
| 1 | Retinal Pigment Epithelium |
| 1 | Retina |
| 1 | Reproduction |
| 1 | Regression Analysis |
| 1 | Registries |
| 1 | Reflex |
| 1 | Referral and Consultation |
| 1 | Reference Values |
| 1 | Reference Standards |
| 1 | Recombinant Proteins |
| 1 | Recognition (Psychology) |
| 1 | Receptors, Scavenger |
| 1 | Receptors, Dopamine D1 |
| 1 | Rare Diseases |
| 1 | Randomized Controlled Trials as Topic |
| 1 | Random Allocation |
| 1 | Quality Control |
| 1 | Putamen |
| 1 | Psychotic Disorders |
| 1 | Psychomotor Performance |
| 1 | Protein Structure, Tertiary |
| 1 | Protein Deglycase DJ-1 |
| 1 | Protein Binding |
| 1 | Probability |
| 1 | Prions |
| 1 | Prion Proteins |
| 1 | Pregnancy |
| 1 | Precision Medicine |
| 1 | Practice Guidelines as Topic |
| 1 | Poultry Diseases |
| 1 | Posture |
| 1 | Population Surveillance |
| 1 | Point Mutation |
| 1 | Pneumonia, Aspiration |
| 1 | Plants |
| 1 | Photic Stimulation |
| 1 | Phosphorylation |
| 1 | Phosphoric Diester Hydrolases |
| 1 | Phosphodiesterase Inhibitors |
| 1 | Personality Disorders |
| 1 | Peptide Fragments |
| 1 | Penetrance |
| 1 | Parkinson Disease, Secondary |
| 1 | Parasites |
| 1 | Oxygen |
| 1 | Outcome Assessment (Health Care) |
| 1 | Organ Specificity |
| 1 | Oncogene Proteins |
| 1 | Oligopeptides |
| 1 | Nucleoside Transport Proteins |
| 1 | Nuclear Medicine |
| 1 | Nuclear Magnetic Resonance, Biomolecular |
| 1 | Nonverbal Communication |
| 1 | Neurotoxins |
| 1 | Neuroprotective Agents |
| 1 | Neuronal Plasticity |
| 1 | Neurogenesis |
| 1 | Neurodegenerative Diseases |
| 1 | Neural Inhibition |
| 1 | Nerve Degeneration |
| 1 | Neostriatum |
| 1 | Neospora |
| 1 | National Institutes of Health (U.S.) |
| 1 | Myoclonic Epilepsies, Progressive |
| 1 | Mutation, Missense |
| 1 | Muscle Rigidity |
| 1 | Movement Disorders |
| 1 | Motor Neurons |
| 1 | Motor Disorders |
| 1 | Mood Disorders |
| 1 | Molecular Structure |
| 1 | Molecular Sequence Annotation |
| 1 | Molecular Chaperones |
| 1 | Models, Econometric |
| 1 | Models, Biological |
| 1 | Mitogen-Activated Protein Kinases |
| 1 | Mitochondrial Turnover |
| 1 | Mitochondrial Proteins |
| 1 | Mitochondrial Membrane Transport Proteins |
| 1 | Microglia |
| 1 | Mice, Inbred BALB C |
| 1 | Metadata |
| 1 | Metabolomics |
| 1 | Mesencephalon |
| 1 | Memory, Short-Term |
| 1 | Membrane Proteins |
| 1 | Malnutrition |
| 1 | Lysosomes |
| 1 | Lysosome-Associated Membrane Glycoproteins |
| 1 | Luminescent Measurements |
| 1 | Logistic Models |
| 1 | Linear Models |
| 1 | Life Style |
| 1 | Lewy Bodies |
| 1 | Learning |
| 1 | Language |
| 1 | LIM-Homeodomain Proteins |
| 1 | Kaplan-Meier Estimate |
| 1 | Intracellular Signaling Peptides and Proteins |
| 1 | Interviews as Topic |
| 1 | Interpersonal Relations |
| 1 | International Cooperation |
| 1 | Intermediate Filaments |
| 1 | Intention |
| 1 | Infusions, Parenteral |
| 1 | Influenza, Human |
| 1 | Infectious Disease Transmission, Vertical |
| 1 | Infection |
| 1 | Indoles |
| 1 | Inclusion Bodies |
| 1 | In Situ Hybridization |
| 1 | Impulsive Behavior |
| 1 | Imaging, Three-Dimensional |
| 1 | Imagination |
| 1 | Image Processing, Computer-Assisted |
| 1 | Image Interpretation, Computer-Assisted |
| 1 | Hypotension, Orthostatic |
| 1 | Hypertension |
| 1 | Hyperkinesis |
| 1 | Hymenolepis |
| 1 | Host-Parasite Interactions |
| 1 | Hippocampus |
| 1 | Heterozygote |
| 1 | Hemiplegia |
| 1 | Heat-Shock Proteins |
| 1 | Healthy Volunteers |
| 1 | Health Status Indicators |
| 1 | Health Knowledge, Attitudes, Practice |
| 1 | Health Care Costs |
| 1 | HSP70 Heat-Shock Proteins |
| 1 | HEK293 Cells |
| 1 | Guidelines as Topic |
| 1 | Guam |
| 1 | Gray Matter |
| 1 | Goals |
| 1 | Glycerides |
| 1 | Globus Pallidus |
| 1 | Glial Cell Line-Derived Neurotrophic Factor |
| 1 | Genotype |
| 1 | Genome, Plant |
| 1 | Genome, Helminth |
| 1 | Genes, Recessive |
| 1 | Genes, Lethal |
| 1 | Genes, Homeobox |
| 1 | Genes, Helminth |
| 1 | Genes, Essential |
| 1 | Genes, Dominant |
| 1 | Gene-Environment Interaction |
| 1 | Gene Knock-In Techniques |
| 1 | Gene Expression |
| 1 | Gene Expression Regulation, Enzymologic |
| 1 | Gels |
| 1 | Gambling |
| 1 | Gait |
| 1 | Gait Ataxia |
| 1 | Furans |
| 1 | Folate Receptor 1 |
| 1 | Fertility |
| 1 | Feedback, Psychological |
| 1 | Fatal Outcome |
| 1 | Family |
| 1 | Facial Recognition |
| 1 | Face |
| 1 | Exome |
| 1 | Evoked Potentials |
| 1 | Evoked Potentials, Visual |
| 1 | Evoked Potentials, Motor |
| 1 | Evidence-Based Medicine |
| 1 | Europe |
| 1 | Essential Tremor |
| 1 | Epidemiologic Methods |
| 1 | Enzyme Inhibitors |
| 1 | Environment |
| 1 | Enteral Nutrition |
| 1 | Endosomes |
| 1 | Endoscopy, Gastrointestinal |
| 1 | Endocytosis |
| 1 | Endocannabinoids |
| 1 | Embryo, Mammalian |
| 1 | Electronic Health Records |
| 1 | Electrodes |
| 1 | Eimeria |
| 1 | Edema |
| 1 | Echinococcus multilocularis |
| 1 | Echinococcus granulosus |
| 1 | Early Diagnosis |
| 1 | Dyskinesia, Drug-Induced |
| 1 | Drug Therapy, Combination |
| 1 | Drug Evaluation |
| 1 | Drug Discovery |
| 1 | Drug Combinations |
| 1 | Drosophila melanogaster |
| 1 | Dopamine Plasma Membrane Transport Proteins |
| 1 | Disruptive, Impulse Control, and Conduct Disorders |
| 1 | Disease |
| 1 | Disease Outbreaks |
| 1 | Disability Evaluation |
| 1 | Diet |
| 1 | Diagnostic Techniques, Neurological |
| 1 | Diagnostic Imaging |
| 1 | Diagnosis, Differential |
| 1 | Dehydration |
| 1 | Deglutition |
| 1 | Deglutition Disorders |
| 1 | Decision Theory |
| 1 | Databases, Genetic |
| 1 | Databases, Bibliographic |
| 1 | Databases as Topic |
| 1 | Data Interpretation, Statistical |
| 1 | Data Curation |
| 1 | DNA, Protozoan |
| 1 | DNA Damage |
| 1 | Cyclooxygenase 2 |
| 1 | Crystallization |
| 1 | Cross-Sectional Studies |
| 1 | Cross-Over Studies |
| 1 | Craniocerebral Trauma |
| 1 | Cost-Benefit Analysis |
| 1 | Corpus Striatum |
| 1 | Confidence Intervals |
| 1 | Computer Simulation |
| 1 | Comprehension |
| 1 | Comparative Genomic Hybridization |
| 1 | Comorbidity |
| 1 | Communication |
| 1 | Chromosome Mapping |
| 1 | Chromatography, Gel |
| 1 | Choroid Plexus |
| 1 | Choice Behavior |
| 1 | Chickens |
| 1 | Chemical Phenomena |
| 1 | Cestode Infections |
| 1 | Cestoda |
| 1 | Cerebrovascular Circulation |
| 1 | Cerebral Cortex |
| 1 | Central Nervous System |
| 1 | Cells, Cultured |
| 1 | Cell Line |
| 1 | Cell Death |
| 1 | Catecholamines |
| 1 | Catechol O-Methyltransferase |
| 1 | Catalysis |
| 1 | Caregivers |
| 1 | Carbidopa |
| 1 | Calorimetry |
| 1 | Body Temperature Regulation |
| 1 | Bipolar Disorder |
| 1 | Biological Specimen Banks |
| 1 | Biological Ontologies |
| 1 | Biological Evolution |
| 1 | Biological Assay |
| 1 | Biocatalysis |
| 1 | Binding Sites |
| 1 | Benzodioxoles |
| 1 | Awareness |
| 1 | Autopsy |
| 1 | Autonomic Nervous System Diseases |
| 1 | Association Learning |
| 1 | Arachidonic Acids |
| 1 | Antipsychotic Agents |
| 1 | Amyotrophic Lateral Sclerosis |
| 1 | Amino Acid Substitution |
| 1 | Alpha Particles |
| 1 | Alopecia |
| 1 | Affective Symptoms |
| 1 | Administration, Cutaneous |
| 1 | Adenylyl Cyclases |
| 1 | Adaptation, Physiological |
| 1 | Action Potentials |
| 1 | Acoustic Stimulation |
| 1 | Accidental Falls |
| 1 | 3-Hydroxyacyl CoA Dehydrogenases |
